Related Experiment Video
Updated: Mar 6, 2026
08:38
Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS
Published on: November 8, 2015
17.5K
Topical tacrolimus in anterior segment inflammatory disorders
1The Eye Center and the Eye Foundation for Research in Ophthalmology, PO Box 55307, Riyadh, 11534 Saudi Arabia.
Eye and Vision (London, England)
|March 14, 2017
Summary
Topical tacrolimus offers a steroid-sparing approach for immune-driven anterior segment inflammation. This calcineurin inhibitor effectively reduces ocular inflammation by suppressing T lymphocytes, mitigating risks associated with prolonged steroid use.
Area of Science:
- Ophthalmology
- Immunology
- Pharmacology
Background:
- Immune-mediated inflammatory anterior segment diseases necessitate potent immunosuppression.
- Topical steroids, while effective, carry significant ocular side effect risks.
- Steroid-sparing immunomodulatory drugs are increasingly utilized to manage these conditions.
Purpose of the Study:
- To review the therapeutic applications of topical tacrolimus in anterior segment inflammation.
- To evaluate tacrolimus as a steroid-sparing agent.
- To discuss its role in managing T cell-mediated anterior segment inflammation.
Main Methods:
- Review of existing literature on topical tacrolimus in ophthalmology.
- Analysis of tacrolimus's mechanism of action as a calcineurin inhibitor.
- Examination of clinical investigations into anterior segment inflammatory disorders.
Main Results:
- Tacrolimus demonstrates T lymphocyte suppression, leading to reduced ocular inflammation.
- Investigational use in various anterior segment inflammatory disorders shows promise.
- Potential for topical tacrolimus as an effective steroid-sparing treatment.
Conclusions:
- Topical tacrolimus is a viable option for managing T cell-mediated anterior segment inflammation.
- It offers a promising steroid-sparing alternative, reducing the risk of steroid-induced complications.
- Further research supports its role in ophthalmic inflammatory disease management.
Related Concept Videos
01:27Open Angle Glaucoma: Treatment
1.1K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.1K
01:28Angle Closure Glaucoma: Treatment
1.5K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.5K